Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial

Leukemia. 2014 Dec;28(12):2418-21. doi: 10.1038/leu.2014.253. Epub 2014 Sep 2.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / complications*
  • Myelodysplastic Syndromes / mortality
  • Platelet Count*
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology*
  • Thrombocytopenia / mortality
  • Thrombopoietin / therapeutic use*
  • Treatment Outcome

Substances

  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim